Table 1.
Demographic and clinical data of the 39 patients involved in the study.
| Variable | Number, mean +/− SD | % | |
|---|---|---|---|
| Gender | M | 24 | 62% |
| F | 15 | 38% | |
|
| |||
| Age (mean +/− SD) | 59,1 +/− 7,6 | — | |
|
| |||
| Age group | 15–25 | 2 | 5,1% |
| 25–35 | 2 | 5,1% | |
| 35–45 | 2 | 5,1% | |
| 45–55 | 4 | 10,2% | |
| 55–65 | 14 | 35,9% | |
| 65–75 | 11 | 28,2% | |
| 75–85 | 4 | 10,2% | |
|
| |||
| Underlying illness | Essential hypertension | 13 | 34,2% |
| Diabetes mellitus | 12 | 30,8% | |
| Immunosuppression | 3 | 8,1% | |
| Chronic renal disease | 2 | 5,4% | |
| Ischemic heart disease | 4 | 10,4% | |
| Others | 12 | 31,6% | |
|
| |||
| Severity | Sepsis | 23 | 50% |
| Severe sepsis | 8 | 17,4% | |
| Septic shock | 15 | 32,6% | |
|
| |||
| Scores of gravity | GLASGOW II | 10,14 +/− 3,76 | — |
| APACHE II | 18,95 +/− 3,76 | — | |
| Predicted mortality | 35,07 +/− 22,2 | — | |
|
| |||
| Length of stay | 41 +/− 6,4 | — | |
|
| |||
| Antecedents | Recent antibiotic use | 13 | 33,3% |
| Recent hospitalization | 23 | 59% | |
| Recent surgery | 14 | 34,5% | |
| Recent corticosteroid therapy | 24 | 61,5% | |
|
| |||
| Outcome | Clinical failure | 17 | 44% |
| Clinical success | 22 | 56,5% | |
|
| |||
| Bacteraemia acquisition time | 16,2 +/− 20,27 | — | |